Top

Intensive Care Medicine

Published in:

01-06-2015 | Correspondence

Immanuel Kant’s categorical imperative and the brain-dead patient

Authors: Erwin J. O. Kompanje, Yorick de Groot

Published in: Intensive Care Medicine | Issue 6/2015

Excerpt

Dear Editor, …

Kompanje EJ, de Groot YJ (2015) Sounding board: is mandatory recovery of organs for transplantation acceptable? Intensive Care Med. doi:10.1007/s00134-015-3681-9

Lazaridis C (2015) Routine recovery of organs for transplantation can be acceptable. Intensive Care Med. doi:10.1007/s00134-015-3739-8

Gray K, Knickman TA, Wegner DM (2011) More dead than dead: perceptions of persons in the persistent vegetative state. Cognition 121:275–280PubMedCrossRef

Hoffenberg R, Lock M, Tilney N et al (1997) Should organs from patients in permanent vegetative state be used for transplantation? Lancet 350:1320–1321PubMedCrossRef

Title: Immanuel Kant’s categorical imperative and the brain-dead patient
Authors: Erwin J. O. Kompanje
Yorick de Groot
Publication date: 01-06-2015
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 6/2015
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-015-3831-0

At a glance: The STEP trials

Springer Medicine

Immanuel Kant’s categorical imperative and the brain-dead patient

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2015

Balancing the “humors” in severe sepsis: still a role for extracorporeal therapies?

Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial

Erratum to: Diastolic dysfunction and mortality in septic patients: a systematic review and meta-analysis

Multinational development and validation of an early prediction model for delirium in ICU patients

Understanding the benefits and harms of oxygen therapy

Use of Type III procollagen measurement as predictor of lung fibroproliferation in ARDS: early measurement for earlier antifibroproliferative therapy?